Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.
作者信息
Minnema M C, van der Veer M S, Aarts T, Emmelot M, Mutis T, Lokhorst H M